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ulation	 of	 patients	 with	 acute	 severe	 respiratory	 failure.	 However,	 contempo-
rary	advances	have	begun	 to	 identify	distinct	 sub-	phenotypes	 that	exist	within	
its	broader	envelope.	These	sub-	phenotypes	have	varied	outcomes	and	respond	
differently	 to	 several	 previously	 studied	 interventions.	 A	 more	 precise	 under-
standing	of	their	pathobiology	and	an	ability	to	prospectively	identify	them,	may	
allow	for	the	development	of	precision	therapies	in	ARDS.	Historically,	animal	
models	 have	 played	 a	 key	 role	 in	 translational	 research,	 although	 few	 studies	
have	 so	 far	assessed	either	 the	ability	of	animal	models	 to	 replicate	 these	 sub-	
phenotypes	or	investigated	the	presence	of	sub-	phenotypes	within	animal	mod-
els.	Here,	in	three	ovine	models	of	ARDS,	using	combinations	of	oleic	acid	and	
intravenous,	 or	 intratracheal	 lipopolysaccharide,	 we	 investigated	 the	 presence	
of	sub-	phenotypes	which	qualitatively	resemble	those	found	in	clinical	cohorts.	
Principal	Component	Analysis	and	partitional	clustering	identified	two	clusters,	
differentiated	 by	 markers	 of	 shock,	 inflammation,	 and	 lung	 injury.	 This	 study	
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1 	 | 	 INTRODUCTION





of	 pharmacological	 treatments.	 Contemporary	 advances	
in	 phenotyping,	 using	 unsupervised	 machine	 learning	
techniques,	have	identified	novel	sub-	phenotypes	in	clin-
ical	 trial	 cohorts	 (Calfee	 et	 al.,	 2014).	These	 phenotypes	





Historically,	 animal	 models	 of	 ARDS	 have	 played	 an	
important	role	in	biological	discovery	and	in	therapeutic	
translation	 (Yehya,	 2019).	 Numerous	 models	 of	 ARDS	
have	 been	 developed	 in	 both	 large	 and	 small	 animals.	
However,	 an	 animal	 model	 that	 fully	 recapitulates	 the	
clinical	 pathobiology	 of	 ARDS	 is	 not	 available.	This	 has	
contributed	 to	 the	 gap	 between	 results	 generated	 from	
preclinical	models	and	those	obtained	in	subsequent	clin-
ical	 trials.	 As	 our	 knowledge	 of	 clinical	 sub-	phenotypes	
grows,	 a	 new	 question	 arises	 for	 those	 modelling	 ARDS	
in	 animals;	 how	 well	 does	 an	 animal	 model	 reflect	 the	
pathobiology	of	a	specific	clinical	sub-	phenotype?	To	an-






lems	 by	 testing	 three	 models	 of	 ARDS	 in	 sheep.	 Using	
a	 combination	 of	 dimensionality	 reduction	 and	 parti-
tional	 clustering,	 we	 investigated	 the	 presence	 of	 sub-	
phenotypes,	 arising	 dependent	 or	 independent	 of	 the	
means	of	injury.	Previously,	others	have	pursued	a	related	




methodology	 for	 investigating	 these	 phenomena	 in	 ani-
mal	models.
2 	 | 	 MATERIALS AND METHODS
2.1	 |	 Study design









2.2	 |	 Animal model
Nineteen	 healthy	 Border	 Leicester	 Cross	 ewes,	 aged	 be-
tween	 1	 and	 3  years	 and	 weighing	 52  kg	 (47–	54),	 were	










kg;	 O1008,	 Sigma-	Aldrich,	 Castle	 Hill,	 NSW,	 Australia),	
with	or	without,	intratracheal	E.	coli	LPS	(100 µg;	O55:B5,	
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Mean pulmonary artery pressureStatic compliance
PEEP
FiO2 adjusted to maintain SpO2 88-93%
PEEP initially set to 5 cmH2O and then adjusted to maintain Pplat < 30 cmH2O
- Total PEEP (intirnsic + extrinsic) not to exceed 20 cmH2O
- PEEP never < 5 cmH2O
Respiratory rate adjusted to maintain pH 7.30-7.45 but limited to <= 35 breaths per minute
I:E ratio 1:1 to 1:3 throughout
(a)
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2.4	 |	 Statistical analysis
Data	are	expressed	as	median	(IQR).	Analysis	was	un-
dertaken	 in	 R	 4.0.3	 (R	 Core	 Team,	 Vienna,	 Austria,	
2020).	The	dataset	for	this	study,	along	with	reproduc-
ible	 code	 and	 supplementary	 methods	 and	 results,	 is	
available	 at	 http://doi.org/10.5281/zenodo.4677513.	
Longitudinal	data	were	analyzed	by	fitting	linear	mixed	
models,	 using	 the	 R	 package	 lme4.	 Non-	longitudinal	
data	were	compared	with	one-	way	ANOVA.	Where	a	
significant	 interaction	 was	 observed,	 post	 hoc	 com-
parisons	 were	 made	 using	 Tukey's	 test,	 using	 the	 R	
package	 rstatix.	 Correction	 for	 multiple	 comparisons	
was	 made	 using	 the	 Benjamini–	Hochberg	 method.	
Frequency	data	were	compared	using	the	Chi-	squared	
test.	 Co-	linearity	 was	 assessed	 by	 calculating	 the	
Spearman	correlation	coefficient	for	each	pair	of	vari-
ables,	 using	 the	 R	 package	 corrplot.	 Principal	 com-






was	 z-	score	 normalized	 by	 subtracting	 the	 variable	




around	 medoids	 (PAM)	 clustering	 was	 performed,	
after	PCA,	on	the	imputed	dataset,	using	the	R	pack-
age	 cluster.	 A	 Euclidean	 distance	 measure	 was	 em-
ployed.	The	optimal	number	of	clusters	to	specify	was	
derived	from	a	“majority”	assessment	of	26 measures,	
using	 the	 NbClust	 package.	 In	 event	 of	 a	 tie	 a	 parsi-
monious	solution	was	preferred.	To	assess	the	stability	






primary	 analysis	 and	 the	 most	 similar	 cluster	 identi-
fied	 for	 each	 random	 re-	sampling.	 A	 mean	 value	 for	
the	 Jaccard	 coefficient,	 for	 the	 sum	 of	 the	 compari-
sons,	was	generated	for	each	cluster.	Z-	scores	for	each	
variable,	by	cluster,	were	descriptively	compared	with	
clusters	 derived	 from	 a	 previously	 published	 latent	
class	analysis	of	the	ARMA	study	(Calfee	et	al.,	2014),	
obtained	 using	 a	 digital	 ruler.	 Statistical	 significance	
was	assumed	if	p < 0.05.









Weight	(kg) 52	(47–	54) 55	(53–	57) 47	(46–	51) 52	(46–	52)
PEEP	(cmH2O) 10	(10–	10) 10	(7.5–	10) 10	(10–	10) 10	(10–	10)
Plateau	pressure	(cmH2O) 27	(26–	30) 26	(26–	27) 27	(26–	29) 29	(28–	34)
Static	compliance	(mL/cmH2O) 16	(14–	22) 21	(16–	25) 16	(14–	18) 16	(14–	16)
PaO2/FiO2	(mmHg) 52	(47–	90) 52	(49–	69) 47	(46–	51) 100	(55–	133)
Effective	shunt	(%) 49	(43–	54) 49	(44–	54) 50	(48–	54) 45	(37–	52)
PaCO2	(mmHg) 49	(46–	57) 47	(46–	53) 52	(46–	57) 49	(48–	53)
pH 7.31	(7.28–	7.35) 7.31	(7.25–	7.32) 7.33	(7.3–	7.38) 7.32	(7.31–	7.37)
Bicarbonate	(mmol/L) 23.8	(22.3–	24.9) 22.4	(21.9–	23.3) 24.3	(23.9–	24.9) 23.4	(22.6–	25.4)
Base	excess	(mmol/L) −0.6	(−2.5	to	1.1) −2.5	(−3	to	−2.4) 1	(0–	1.8) 0.8	(−1.4	to	2.6)
Heart	rate	(bpm) 112	(102–	134) 121	(96–	134) 111	(100–	132) 112	(106–	117)
Mean	arterial	pressure	(mmHg) 96	(85–	109) 104	(96–	111) 80	(76–	92) 108	(99–	115)
Mean	pulmonary	arterial	pressure	(mmHg) 21	(19–	25) 22	(19–	26) 23	(20–	27) 20	(19–	21)
Central	venous	pressure	(mmHg) 12	(9–	13) 13	(12–	15) 11	(9–	13) 11	(3–	19)
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3 	 | 	 RESULTS
Baseline	characteristics	at	injury	(0 h)	are	summarized	in	
Table	1	and	in	Table	E1	(Supplementary	results	available	
at	 http://doi.org/10.5281/zenodo.4677513).	 All	 animals	
completed	the	study	protocol	and	were	euthanized	at	6 h	






The	 infusion	 of	 OA	 produced	 severe	 lung	 injury	
(PaO2/FiO2	<100 mmHg).	However,	oxygenation	began	
to	recover	within	1 h	(Figure	1).	LPS	consistently	main-




3.1	 |	 The addition of LPS increases the 
plasma concentration of interleukin- 6
Both	 intravenous	and	 intratracheal	LPS	 increased	 the	
plasma	 concentration	 of	 IL-	6	 (group:time,	 p	 <0.001)	
when	compared	to	OA	alone	(Figure	E1	and	Tables	E4	
and	 E5).	 The	 use	 of	 intravenous	 LPS	 was	 associated	
with	 non-	sustained	 increases	 in	 the	 plasma	 concen-
tration	 of	 IL-	8	 (group:time,	 p  <  0.001).	 Similarly,	 the	
use	of	 intravenous	LPS	resulted	in	 increase	 in	plasma	
IL-	10	 (group:time,	 p  <  0.001).	 All	 three	 injury	 meth-
ods	 were	 associated	 with	 low	 plasma	 levels	 of	 IL-	1β.	
Cytokine	 concentrations	 in	 bronchoalveolar	 lavage	
(BAL)	fluid	were	 less	distinct	between	groups	(Figure	
E1	 and	 Tables	 E4	 and	 E5).	 Animals	 injured	 with	 in-
travenous	 LPS,	 as	 compared	 to	 OA	 alone,	 had	 higher	
white	cell	and	neutrophil	counts	at	6 h	(p = 0.049	and	
0.034,	respectively).
3.2	 |	 In the first 6 hours, intravenous LPS 
induces more severe shock in comparison 
to intratracheal LPS or OA alone
All	 pulmonary	 injury	 methods	 produced	 shock	 requir-
ing	 vasopressor	 support	 (Figure	 E2).	 While	 reductions	
in	 MAP	 from	 baseline	 to	 6  h	 were	 greater	 in	 animals	
receiving	 LPS,	 these	 differences	 were	 not	 statistically	








comparisons,	 there	 were	 no	 significant	 differences	 be-
tween	groups	in	indices	of	renal	function.
3.3	 |	 Two sub- phenotypes are 
identifiable and are associated with the 
method of injury
A	priori	assessment	of	the	data	suggested	that	two	clus-
ters	 were	 the	 optimal	 partition	 of	 our	 data	 (Table	 E6).	
The	 distribution	 of	 the	 clusters	 in	 two-	dimensional	
space	is	shown	in	Figure	2.	Animals	in	cluster	B	(n = 4)	
tended	to	have	a	 lower	MAP,	 lower	urine	output,	were	





good	 (mean	 Jaccard	 similarities,	 0.85	 Cluster	 A,	 0.71	
Cluster	B).
3.4	 |	 Differences in variables 
describing the severity of shock and of lung 





differentiating	 variables	 we	 performed	 principal	 compo-
nent	analysis	(PCA).	In	total,	eight	principal	components	
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Hyper-inflammatory phenotype vs. Cluster B Hypo-inflammatory phenotype vs. Cluster A
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4 	 | 	 DISCUSSION
In	 a	 study	 combining	 three	 ovine	 models	 of	 ARDS,	 we	
provide	 a	 preliminary	 exploration	 of	 sub-	phenotypes	 oc-
curring	early	in	the	course	of	illness.	In	doing	so,	we	pro-
vide	the	first	characterization	of	OA	and	LPS	“double-	hit”	
models	of	ARDS	in	 large	animals.	 In	 this	study,	OA	was	
capable	of	inducing	severe	acute	respiratory	failure,	how-





els	 of	 IL-	6	 were	 higher	 in	 animals	 receiving	 intravenous	
LPS,	 however	 BAL	 concentrations	 remained	 unchanged.	






entiated	 along	 PC1.	 Cluster	 membership	 was	 associated	
with	method	of	injury	with	more	animals	belonging	to	the	
intravenous	LPS	group	in	cluster	B.	These	data	may	have	
implications	 for	 translational	 research	 in	 ARDS.	 First,	
the	 presence	 of	 sub-	phenotypes	 in	 animal	 models	 opens	
the	 possibility	 of	 developing	 phenotype-	specific	 models.	
Second,	 unappreciated	 sub-	phenotypic	 variation	 in	 exist-
ing	or	future	preclinical	studies	may	result	in	differential	
treatment	effects	where	interventions	are	being	studied.








intravenous	 infusion	 of	 OA	 results	 in	 rapid-	onset	 lung	
injury,	largely	due	to	pulmonary	endothelial	damage	and	
the	 formation	 of	 proteinaceous	 edema	 in	 alveoli	 (Wang	
et	al.,	2008).	This	is	evident	in	our	data,	where	OA	infu-






signalling	 pathways	 known	 to	 be	 important	 in	 clinical	
ARDS,	such	as	NF-	κB	(Moine	et	al.,	2000).	In	this	study,	
animals	 receiving	 OA	 alone	 had	 consistently	 lower	 lev-
els	 of	 pro-	inflammatory	 cytokines	 measured	 in	 plasma.	
These	 differences	 may	 also	 be	 accounted	 for	 by	 the	 fact	





of	 a	 non-	pulmonary	 etiology.	 The	 addition	 of	 LPS	 may	
address	some	of	these	limitations.	As	a	common	constitu-
ent	of	Gram-	negative	bacterial	cell	walls,	LPS	participates	
in	 the	 pathology	 of	 causes	 of	 direct	 and	 indirect	 ARDS.	
The	 mechanisms	 of	 LPS-	mediated	 injury	 include;	 lung	
epithelial	injury	(involving	NF-	κB	induction),	pulmonary	
endothelial	 damage,	 neutrophilic	 infiltration,	 and	 the	









An	 expanding	 number	 of	 studies	 has	 identified	 two	
consistent	 sub-	phenotypes	 of	 ARDS	 in	 clinical	 cohorts,	
which	 have	 been	 broadly	 characterized	 as	 hyper-	 and	
hypo-	inflammatory	 (Bos	 et	 al.,	 2017;	 Calfee	 et	 al.,	 2014,	
2018;	Famous	et	al.,	2017;	Sinha	et	al.,	2018).	These	sub-	
phenotypes	have	distinct	outcomes	and,	 in	 retrospective	
analysis,	have	been	shown	 to	 respond	differently	 to	 sev-
eral	 interventions.	 Related	 sub-	phenotypes	 have	 also	
been	 identified	 in	 other	 conditions	 causing	 critical	 ill-
ness	(Neyton	et	al.,	2019;	Seymour,	Kennedy,	et	al.,	2019;	
Vranas	 et	 al.,	 2017).	 However,	 the	 predominant	 cluster-
ing	 method	 employed	 in	 clinical	 cohorts,	 finite	 mixture	









In	 this	 study,	 partitional	 clustering,	 as	 opposed	 to	
model-	based	 clustering,	 was	 used	 to	 investigate	 the	
presence	 of	 sub-	phenotypes	 within	 the	 combined	 study.	
Partitional	 clustering	 is	 a	 common	 method	 to	 partition	
objects,	 in	 this	case	animals,	 into	an	optimal	number	of	
related	clusters	 (Steinley,	2006).	The	aim	 is	 to	maximize	
homogeneity	within	clusters	while	minimizing	it	between	
them.	The	algorithm	is	agnostic	to	the	number	of	clusters,	
therefore	 an	 assessment	 of	 the	 optimal	 number	 of	 clus-
ters	was	made	before	clustering	was	applied.	This	is	unlike	
model-	based	clustering	where	parametric	techniques	can	









The	 sub-	phenotypes	 identified	 in	 this	 study	 share	
some	 qualitative	 similarities	 with	 those	 described	 in	
ARDS	 clinical	 cohorts.	 Cluster	 B	 animals	 in	 this	 study	
exhibited	 higher	 levels	 of	 plasma	 IL-	6,	 IL-	8,	 creatinine,	
and	serum	sodium,	with	elevated	prothrombin	times	and	
heart	 rates.	 On	 the	 other	 hand,	 they	 had	 lower	 serum	





ing	and	 features	 such	as	 the	magnitude	of	z-	scores	and	
the	 rank	 order	 of	 variables	 should	 be	 interpreted	 with	












stantially	 greater	 numbers.	 Second,	 although	 differences	




which	 there	 is	 likely	 to	 be	 lag	 after	 injury,	 such	 as	 renal	
dysfunction.	 Third,	 the	 choice	 of	 clustering	 technique	 is	
flexible,	 given	 the	 variety	 available	 to	 investigators.	 PAM	
has	several	specific	disadvantages,	not	least	of	which	is	its	
vulnerability	 to	 the	 influence	 of	 outliers.	 Future	 studies	
may	seek	to	validate	clustering	solutions	by	adopting	more	
than	one	technique	(Castela	Forte	et	al.,	2019).
In	 conclusion,	 we	 identified	 preliminary	 evidence	 of	
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